This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Tjan-Heijnen VC et al. (2002) An analysis of chemotherapy dose and dose-intensity in small-cell lung cancer: lessons to be drawn. Ann Oncol 13: 1519–1530
Pettengell R et al. (1995) Multicyclic, dose-intensive chemotherapy supported by sequential reinfusion of hematopoietic progenitors in whole blood. J Clin Oncol 13: 148–156
Norton L (2005) Conceptual and practical implications of breast tissue geometry: toward a more effective, less toxic therapy. Oncologist 10: 370–381
Citron ML et al. (2003) Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741. J Clin Oncol 21: 1431–1439
Buchholz E et al. (2003) Final results from a single centre, controlled study of standard versus dose intensified chemotherapy with sequential reinfusion of haemopoietic progenitor cells in SCLC. Proc Am Soc Clin Oncol 22: 2572
Acknowledgements
The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Kiura, K., Saijo, N. Can dose-dense chemotherapy improve outcome in patients with better-prognosis small-cell lung cancer?. Nat Rev Clin Oncol 2, 610–611 (2005). https://doi.org/10.1038/ncponc0357
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncponc0357